IL-17 in psoriasis. The final frontier or just another brick in the wall?
Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, España. Electronic address: jmcarrascosac@hotmail.com.
J M
JM
Carrascosa
Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, España.
L
L
Puig
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy / Q000276:immunology; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D020381:Interleukin-17 / Q000037:antagonists & inhibitors / Q000502:physiology*; D015603:Keratinocytes / Q000276:immunology; D018448:Models, Immunological; D011565:Psoriasis / Q000188:drug therapy / Q000276:immunology*; D012867:Skin / Q000276:immunology; D058504:Th17 Cells / Q000276:immunology
D000911:Antibodies, Monoclonal; D016207:Cytokines; D020381:Interleukin-17